From the moment they're born, newborns—or, specifically, their immune systems—must learn to fight germs without harming their own tissues.
Vaxcyte, Inc. announced that it has progressed to Stage 2 of its Phase 2 infant study for the VAX-31 pneumococcal conjugate vaccine after a review of Stage 1 safety and tolerability data. VAX-31 ...
The smart MAIJU jumpsuit offers a novel approach to at-home monitoring of infants' early motor development. The wearable device combines expertise in medicine, measuring technology and AI, enabling ...
Indications for Radiotherapy and Chemotherapy After Complete Resection in Rhabdomyosarcoma: A Report From the Intergroup Rhabdomyosarcoma Studies I to III PURPOSE: To assess the long-term ...